The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Z)-3-(2-(4-fluorophenylamino)-4-oxothiazol-5(4H)-ylidene)-1-methylindolin-2-one ID: ALA212045
PubChem CID: 135418652
Max Phase: Preclinical
Molecular Formula: C18H12FN3O2S
Molecular Weight: 353.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1C(=O)/C(=C2\SC(Nc3ccc(F)cc3)=NC2=O)c2ccccc21
Standard InChI: InChI=1S/C18H12FN3O2S/c1-22-13-5-3-2-4-12(13)14(17(22)24)15-16(23)21-18(25-15)20-11-8-6-10(19)7-9-11/h2-9H,1H3,(H,20,21,23)/b15-14-
Standard InChI Key: ONHADLRFUHGNIQ-PFONDFGASA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
-4.3450 -18.8858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3461 -19.7128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6317 -20.1254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6335 -18.4733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9185 -18.8822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9136 -19.7128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1222 -19.9649 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.6378 -19.2900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1301 -18.6210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8133 -19.2851 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.8798 -17.8353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0965 -17.5721 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.1013 -16.7476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8871 -16.4974 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3678 -17.1673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4373 -16.2590 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2672 -16.6877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2437 -17.5102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9472 -17.9388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6716 -17.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6882 -16.7145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9840 -16.2896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3765 -17.9709 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.1923 -17.1709 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.8628 -20.7476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 6 2 0
1 2 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 11 1 0
5 4 2 0
13 16 1 0
6 7 1 0
16 17 1 0
7 8 1 0
17 18 2 0
8 9 1 0
18 19 1 0
9 5 1 0
19 20 2 0
4 1 1 0
20 21 1 0
8 10 2 0
21 22 2 0
22 17 1 0
5 6 1 0
20 23 1 0
9 11 2 0
15 24 2 0
11 12 1 0
7 25 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 353.38Molecular Weight (Monoisotopic): 353.0634AlogP: 3.25#Rotatable Bonds: 1Polar Surface Area: 61.77Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 2.61CX LogD: 2.61Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.80Np Likeness Score: -1.46
References 1. Kim ND, Yoon J, Kim JH, Lee JT, Chon YS, Hwang MK, Ha I, Song WJ.. (2006) Putative therapeutic agents for the learning and memory deficits of people with Down syndrome., 16 (14): [PMID:16698266 ] [10.1016/j.bmcl.2006.04.042 ]